Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ICL Group Ltd. Director's Dealing 2026

Mar 31, 2026

6843_rns_2026-03-31_a11764c0-8bb4-4c25-8634-5e5415866ce2.htm

Director's Dealing

Open in viewer

Opens in your device viewer

Perelman Uri - Initial Statement of Beneficial Ownership of Securities false

איי.סי.אל גרופ בע"מ 2 380
ICL GROUP LTD
Corporation no: 520027830 12435
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 31/03/2026
www.isa.gov.il www.tase.co.il Reference: 2026-02-030086 Time of broadcast: 01:54 01:54

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPerelman Uri - Initial Statement of Beneficial Ownership of Securities

Uri_Perelman_Form_3_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE Date of revision of form structure: 06/08/2024
Address: ARANHA ST 23 , TEL AVIV 6107025   ISRAEL , Tel: 03-6844400 , 03-6844440 Fax: 03-6844444
E-mail address: [email protected]   Company site: www.icl-group.com
Previous names of reporting entity: ICL-ISRAEL CHEMICALS LTD
Name of the Signatory: Geva Harel Lilach Position of Signatory in the reporting corporation: Senior Vice President & General Counsel Name of Employer Company:
Address: Arnha 23 , Tel Aviv 6120201 Telephone: 03-6844459 Facsimile: 03-6844419 E-mail: [email protected] 1